Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Anticancer effects of olive oil polyphenols and their combinations with anticancer drugs (CROSBI ID 268467)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Torić, Jelena ; Karković Marković, Ana ; Jakobušić Brala, Cvijeta ; Barbarić, Monika Anticancer effects of olive oil polyphenols and their combinations with anticancer drugs // Acta pharmaceutica, 69 (2019), 461-482

Podaci o odgovornosti

Torić, Jelena ; Karković Marković, Ana ; Jakobušić Brala, Cvijeta ; Barbarić, Monika

engleski

Anticancer effects of olive oil polyphenols and their combinations with anticancer drugs

Cancer presents one of the main causes of death in the world. The cancer treatment includes the administration of one or more anticancer drugs, commonly known as chemotherapy. The biggest issue concerning the chemotherapeutics is their toxicity on normal cells and persisting side effects. One approach to the issue is chemoprevention and another one is discovery of more effective drugs or drug combinations, including combinations with polyphenols. Olive oil polyphenols (OOPs), especially hydroxytyrosol (HTyr), tyrosol (Tyr) and their derivatives oleuropein (Ole), oleacein and oleocanthal (Oc) express anticancer activity on different cancer models. Recent studies report that phenolic extract of virgin olive oil may be more effective than individual phenolic compounds. Also, there is a growing body of evidence about the combined treatment of OOPs with various anticancer drugs, such as cisplatin, tamoxifen, doxorubicin and others. These novel approaches may present a advanced strategy in prevention and treatment of cancer.

olive polyphenols, anticancer, chemoprotective, synergism

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

69

2019.

461-482

objavljeno

1330-0075

1846-9558

Povezanost rada

Farmacija

Indeksiranost